Zacks Investment Research
07 May 2026, 22:55 UTC · 19w ago
Arcturus Therapeutics (ARCT) Reports Q1 Loss, Lags Revenue Estimates
Verdict
Headline leans bearish. We score ARCT +0.10.
Score contradicts the headline.
- Headline says
Leans bearish
From its wording — no explicit rating
- Expected · ARCT
+0.10slightly bullish




